New targeted therapy shows promise against breast cancer
Pfizer's new targeted drug, palbociclib, has been shown to halt the progression of the most common form of advanced breast cancer in women, researchers said Saturday.
May 30, 2015
0
140
Archive: 30/05/2015
Combining targeted drug with chemotherapy offers longer life to b-cell cancer patients
Because of the significant benefit found in combining the targeted drug ibrutinib with standard chemotherapy for relapsed chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), an interim analysis has closed ...
May 30, 2015
Targeted drug can 'diminish the suffering' of myelofibrosis
Use of the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis in patients, says a Mayo Clinic researcher who co-led PERSIST-1, the worldwide phase III clinical trial that tested ...
May 30, 2015
Removing more breast tissue reduces by half the need for second cancer surgery
Removing more tissue during a partial mastectomy could spare thousands of breast cancer patients a second surgery, according to a Yale Cancer Center study. The findings were published online May 30 in the New England Journal ...
May 30, 2015
